Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
Vertex Pharmaceuticals ( VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic ...
The Armenian Reporter8h
Caprock Group LLC Buys 1,636 Shares of FedEx Co. (NYSE:FDX)
Caprock Group LLC boosted its stake in shares of FedEx Co. (NYSE:FDX – Free Report) by 19.1% in the fourth quarter, according ...
news.stocktradersdaily9h
Trend Tracker for (FDX)
Short FDX slightly under 265.57, target n/a, stop loss @ 266.34 Check the time stamp on this data. Updated AI-Generated ...
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...
FedEx Corporation (FDX): Among the Large-Cap Stocks Insiders Are Buying Recently
We recently compiled a list of the 10 Large-Cap Stocks Insiders Are Buying Recently. In this article, we are going to take a look at where FedEx Corporation (NYSE:FDX) stands against the other ...